Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BRIP1 |
| Variant | P47A |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | BRIP1 P47A lies within the helicase ATP-binding domain of the Brip1 protein (UniProt.org). P47A partially rescues mitomycin-induced DNA cross-linking damage in cell culture (PMID: 31822495) and results in a loss of ATPase (PMID: 11301010, PMID: 14983014) and helicase activity (PMID: 11301010, PMID: 14983014, PMID: 33028645), and leads to greater chromosomal aberrations and cell cycle effects compared to wild-type Brip1 in culture (PMID: 31822495), and therefore, is predicted to lead to a loss of Brip1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 P47A |
| Transcript | NM_032043.3 |
| gDNA | chr17:g.61859862G>C |
| cDNA | c.139C>G |
| Protein | p.P47A |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_047436897.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525340 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525333.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525335 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525341.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525336.2 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436894.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525339.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525340.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436892.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436902.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525341 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525332.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525333 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436895.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436901.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436903.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436896.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| NM_032043 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525341.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525336 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525335.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525334.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436891.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525339 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525332 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| NM_032043.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525334 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525335.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436904.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436900.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436899.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525337.2 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525336.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| NM_032043.2 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525337 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525339.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525332.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525340.3 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_047436893.1 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525333.4 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| XM_011525334.2 | chr17:g.61859862G>C | c.139C>G | p.P47A | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|